Personalis(PSNL)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

PSNL Personalis

盘前交易 01-14 04:07:58 EST

8.78

+0.21

+2.45%

最高9.18	最低8.46	成交量116.06万
今开8.66	昨收8.57	日振幅8.40%
总市值7.79亿	流通市值4.62亿	总股本8,868万
成交额1,025万	换手率2.21%	流通股本5,259万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"PSNL","market":"US","secType":"STK","nameCN":"Personalis","latestPrice":8.78,"timestamp":1768338000000,"preClose":8.57,"halted":0,"volume":1160624,"delay":0,"changeRate":0.024504084014002225,"floatShares":52594480,"shares":88677062,"eps":-0.875494,"marketStatus":"盘前交易","change":0.21,"latestTime":"01-14 04:07:58 EST","open":8.66,"high":9.18,"low":8.46,"amount":10250440.825663999,"amplitude":0.084014,"askPrice":14.04,"askSize":200,"bidPrice":8.8,"bidSize":13,"shortable":3,"etf":0,"ttmEps":-0.875494,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1768401000000},"marketStatusCode":1,"adr":0,"listingDate":1561003200000,"exchange":"NASDAQ","adjPreClose":8.78,"postHourTrading":{"tag":"盘后","latestPrice":8.9936,"preClose":8.78,"latestTime":"19:54 EST","volume":15651,"amount":137358.1839,"timestamp":1768352072286},"volumeRatio":0.878931406277552,"impliedVol":2.9435,"impliedVolPercentile":0.916},"requestUrl":"/m/hq/s/PSNL","defaultTab":"news","newsList":[{"id":"1136956368","title":"Personalis发布应用超灵敏ctDNA检测监测所有实体肿瘤癌症免疫疗法反应的新研究","url":"https://stock-news.laohu8.com/highlight/detail?id=1136956368","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1136956368?lang=zh_cn&edition=full","pubTime":"2025-12-17 19:05","pubTimestamp":1765969528,"startTime":"0","endTime":"0","summary":"Personalis发布应用超灵敏ctDNA检测监测所有实体肿瘤癌症免疫疗法反应的新研究","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","PSNL"],"gpt_icon":0},{"id":"2588809952","title":"Personalis, Inc.盘中异动 快速上涨5.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588809952","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588809952?lang=zh_cn&edition=full","pubTime":"2025-12-02 22:52","pubTimestamp":1764687154,"startTime":"0","endTime":"0","summary":"北京时间2025年12月02日22时52分，Personalis, Inc.股票出现波动，股价急速拉升5.76%。Personalis, Inc.股票所在的生命科学行业中，整体涨幅为0.15%。其相关个股中，Personalis, Inc.、Xwell, Inc.、Genedx Holdings Corp.涨幅较大，Prophase Labs, Inc.、Ispecimen Inc.、Check-Cap Ltd.较为活跃，换手率分别为4.85%、0.62%、0.38%，振幅较大的相关个股有Prophase Labs, Inc.、Personalis, Inc.、Billiontoone, Inc.，振幅分别为8.02%、5.89%、4.90%。Personalis, Inc.公司简介：Personalis Inc 是一家基因组测序和分析解决方案提供商，支持个性化癌症疫苗和其他下一代癌症免疫疗法的开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251202225235a71f756c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251202225235a71f756c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","PSNL"],"gpt_icon":0},{"id":"1172154193","title":"Personalis Inc - 自12月1日起，下一项Personal Dx乳腺MRD测试的报销率设定为4,266美元 - SEC文件","url":"https://stock-news.laohu8.com/highlight/detail?id=1172154193","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1172154193?lang=zh_cn&edition=full","pubTime":"2025-11-25 19:16","pubTimestamp":1764069372,"startTime":"0","endTime":"0","summary":"Personalis Inc - 自12月1日起，下一项Personal Dx乳腺MRD测试的报销率设定为4,266美元 - SEC文件","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","PSNL"],"gpt_icon":0},{"id":"1165828576","title":"Personalis Inc - CMS修订癌症后续监测个人测试的报销率 - SEC文件","url":"https://stock-news.laohu8.com/highlight/detail?id=1165828576","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1165828576?lang=zh_cn&edition=full","pubTime":"2025-11-25 19:16","pubTimestamp":1764069371,"startTime":"0","endTime":"0","summary":"Personalis Inc - CMS修订癌症后续监测个人测试的报销率 - SEC文件","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","PSNL"],"gpt_icon":0},{"id":"2581485046","title":"Personalis, Inc.盘中异动 早盘股价大跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2581485046","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581485046?lang=zh_cn&edition=full","pubTime":"2025-11-07 23:55","pubTimestamp":1762530941,"startTime":"0","endTime":"0","summary":"北京时间2025年11月07日23时55分，Personalis, Inc.股票出现异动，股价急速下挫5.01%。Personalis, Inc.股票所在的生命科学行业中，整体涨幅为0.14%。Personalis, Inc.公司简介：Personalis Inc 是一家基因组测序和分析解决方案提供商，支持个性化癌症疫苗和其他下一代癌症免疫疗法的开发。消息层面，截至23时55分，《H.C. Wainwright维持Personalis买入评级，上调目标价至10美元》资讯为影响Personalis, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251107235541975aede2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251107235541975aede2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","PSNL"],"gpt_icon":0},{"id":"2574171972","title":"Personalis, Inc.盘中异动 股价大涨5.28%报7.97美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2574171972","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574171972?lang=zh_cn&edition=full","pubTime":"2025-10-08 21:46","pubTimestamp":1759931203,"startTime":"0","endTime":"0","summary":"北京时间2025年10月08日21时46分，Personalis, Inc.股票出现波动，股价快速上涨5.28%。Personalis, Inc.股票所在的生命科学行业中，整体涨幅为0.18%。其相关个股中，Bioaffinity Technologies Inc C/Wts 07/09/2027 、Bioaffinity Technologies, Inc.、Personalis, Inc.涨幅较大，Bioaffinity Technologies, Inc.、Mainz Biomed N.V.、Applied Dna Sciences, Inc.较为活跃，换手率分别为831.91%、112.76%、4.42%，振幅较大的相关个股有Bioaffinity Technologies Inc C/Wts 07/09/2027 、Bioaffinity Technologies, Inc.、Mainz Biomed N.V.，振幅分别为54.52%、20.82%、12.72%。Personalis, Inc.公司简介：Personalis Inc 是一家基因组测序和分析解决方案提供商，支持个性化癌症疫苗和其他下一代癌症免疫疗法的开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251008214643a4573254&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251008214643a4573254&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","PSNL"],"gpt_icon":0},{"id":"2572636515","title":"Personalis, Inc.盘中异动 早盘大幅上涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2572636515","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2572636515?lang=zh_cn&edition=full","pubTime":"2025-10-03 22:40","pubTimestamp":1759502412,"startTime":"0","endTime":"0","summary":"北京时间2025年10月03日22时40分，Personalis, Inc.股票出现异动，股价快速拉升5.02%。Personalis, Inc.股票所在的生命科学行业中，整体涨幅为2.55%。其相关个股中，Grail, Inc.、Twist Bioscience Corporation、万基遗传涨幅较大，Applied Dna Sciences, Inc.、Bioaffinity Technologies, Inc.、Ispecimen Inc.较为活跃，换手率分别为5.82%、3.03%、1.85%，振幅较大的相关个股有Genedx Holdings Corp C/Wts 22/07/2026 、Bioaffinity Technologies Inc C/Wts 07/09/2027 、Grail, Inc.，振幅分别为17.78%、15.70%、8.97%。Personalis, Inc.公司简介：Personalis Inc 是一家基因组测序和分析解决方案提供商，支持个性化癌症疫苗和其他下一代癌症免疫疗法的开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251003224012a6ac39e1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251003224012a6ac39e1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","PSNL"],"gpt_icon":0},{"id":"2568321953","title":"Personalis, Inc.盘中异动 临近午盘股价大涨5.33%报6.13美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2568321953","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568321953?lang=zh_cn&edition=full","pubTime":"2025-09-19 23:39","pubTimestamp":1758296387,"startTime":"0","endTime":"0","summary":"北京时间2025年09月19日23时39分，Personalis, Inc.股票出现异动，股价快速拉升5.33%。截至发稿，该股报6.13美元/股，成交量28.7354万股，换手率0.32%，振幅5.58%。Personalis, Inc.股票所在的生命科学行业中，整体跌幅为0.62%。Personalis, Inc.公司简介：Personalis Inc 是一家基因组测序和分析解决方案提供商，支持个性化癌症疫苗和其他下一代癌症免疫疗法的开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250919233947a4376a04&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250919233947a4376a04&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","PSNL"],"gpt_icon":0},{"id":"2567190639","title":"生物科技股集体重挫！报道称特朗普政府将儿童死亡甩锅新冠疫苗接种","url":"https://stock-news.laohu8.com/highlight/detail?id=2567190639","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2567190639?lang=zh_cn&edition=full","pubTime":"2025-09-13 06:38","pubTimestamp":1757716705,"startTime":"0","endTime":"0","summary":"研发新冠疫苗的BioNTech盘中跌超10%、莫德纳跌超7%、Novavax跌超4%。投资者担心，如果特朗普政府进一步收紧疫苗接种政策，可能对疫苗制造商的业务造成重大冲击，特别是对莫德纳这类高度依赖新冠疫苗收入的公司。更新中","market":"us","thumbnail":"https://static.tigerbbs.com/632b4e916ff966270173f4303843021f","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/632b4e916ff966270173f4303843021f"],"rights":{"source":"wallstreetcn_hot_news","url":"https://wallstreetcn.com/articles/3755508","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"ae8bc75ba4d1918dcafc0476d86c6d53","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3755508","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"生物科技股集体重挫！报道称特朗普政府将儿童死亡甩锅新冠疫苗接种","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"wallstreetcn_hot_news","symbols":["ABUS","STRO","SRPT","MRK","PGEN","BMY","PFE","NVS","TARS","AZN","KALV","MRNA","NVAX","TRVI","TVTX","PSNL","ARCT","BNTX","BK4009"],"gpt_icon":1},{"id":"1107635607","title":"Cate临床试验启动，使用超敏感Next Personal检测验证循环肿瘤DNA指导乳腺癌治疗的临床实用性","url":"https://stock-news.laohu8.com/highlight/detail?id=1107635607","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1107635607?lang=zh_cn&edition=full","pubTime":"2025-09-11 04:06","pubTimestamp":1757534776,"startTime":"0","endTime":"0","summary":"Cate临床试验正式启动，旨在验证使用超敏感Next Personal检测进行循环肿瘤DNA指导的乳腺癌治疗方案的临床实用性。该试验将评估这一创新检测技术在乳腺癌精准治疗中的应用价值和临床效果。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","PSNL"],"gpt_icon":0},{"id":"1142043774","title":"Personalis公布里程碑式新辅助肺癌试验新数据，显示超敏感肿瘤知情MRD检测技术优势","url":"https://stock-news.laohu8.com/highlight/detail?id=1142043774","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1142043774?lang=zh_cn&edition=full","pubTime":"2025-09-04 04:06","pubTimestamp":1756929985,"startTime":"0","endTime":"0","summary":"Personalis公布里程碑式新辅助肺癌试验新数据，显示超敏感肿瘤知情MRD检测技术优势","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","PSNL"],"gpt_icon":0},{"id":"2561728719","title":"Personalis, Inc.盘中异动 早盘股价大涨5.15%报4.90美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2561728719","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2561728719?lang=zh_cn&edition=full","pubTime":"2025-08-22 22:08","pubTimestamp":1755871739,"startTime":"0","endTime":"0","summary":"北京时间2025年08月22日22时08分，Personalis, Inc.股票出现异动，股价急速上涨5.15%。Personalis, Inc.股票所在的生命科学行业中，整体涨幅为2.00%。其相关个股中，Personalis, Inc.、Twist Bioscience Corporation、Insight Molecular Diagnostics Inc.涨幅较大，Ispecimen Inc.、Applied Dna Sciences, Inc.、Exagen Inc.较为活跃，换手率分别为17.44%、3.27%、1.05%，振幅较大的相关个股有Ispecimen Inc.、Bioaffinity Technologies, Inc.、燃石医学，振幅分别为10.92%、10.04%、9.94%。Personalis, Inc.公司简介：Personalis Inc 是一家基因组测序和分析解决方案提供商，支持个性化癌症疫苗和其他下一代癌症免疫疗法的开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250822220859a6f5b530&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250822220859a6f5b530&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PSNL","BK4121"],"gpt_icon":0},{"id":"2558368489","title":"Personalis, Inc.2025财年第二财季实现净利润-20.06百万美元，同比减少56.72%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558368489","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558368489?lang=zh_cn&edition=full","pubTime":"2025-08-11 00:01","pubTimestamp":1754841695,"startTime":"0","endTime":"0","summary":"8月11日，Personalis, Inc.公布财报，公告显示公司2025财年第二财季净利润为-20.06百万美元，同比减少56.72%；其中营业收入为17.20百万美元，同比减少23.83%，每股基本收益为-0.23美元。从资产负债表来看，Personalis, Inc.总负债67.85百万美元，其中短期债务9.05百万美元，资产负债比为0.04，流动比率为0.07。机构评级：截至2025年8月11日，当前有8家机构对Personalis, Inc.目标价做出预测，其中目标均价为7.19美元，其中最低目标价为5.00美元，最高目标价为9.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811000349a6de081d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811000349a6de081d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PSNL"],"gpt_icon":0},{"id":"2557315701","title":"Personalis, Inc.盘中异动 下午盘急速拉升5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557315701","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557315701?lang=zh_cn&edition=full","pubTime":"2025-08-06 01:48","pubTimestamp":1754416119,"startTime":"0","endTime":"0","summary":"北京时间2025年08月06日01时48分，Personalis, Inc.股票出现异动，股价快速拉升5.03%。Personalis, Inc.股票所在的生命科学行业中，整体跌幅为0.46%。其相关个股中，Bioaffinity Technologies Inc C/Wts 07/09/2027 、Castle Biosciences, Inc.、Fulgent Genetics, Inc.涨幅较大，Advanced Biomed Inc.、Applied Dna Sciences, Inc.、Mainz Biomed N.V.较为活跃，换手率分别为116.31%、10.11%、4.92%，振幅较大的相关个股有Advanced Biomed Inc.、Bioaffinity Technologies Inc C/Wts 07/09/2027 、Genedx Holdings Corp C/Wts 22/07/2026 ，振幅分别为75.83%、52.92%、28.11%。Personalis, Inc.公司简介：Personalis Inc 是一家基因组测序和分析解决方案提供商，支持个性化癌症疫苗和其他下一代癌症免疫疗法的开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806014839a6d4eb78&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806014839a6d4eb78&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","PSNL"],"gpt_icon":0},{"id":"2555833047","title":"Personalis, Inc.盘中异动 早盘大幅拉升5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555833047","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555833047?lang=zh_cn&edition=full","pubTime":"2025-07-30 21:39","pubTimestamp":1753882752,"startTime":"0","endTime":"0","summary":"北京时间2025年07月30日21时39分，Personalis, Inc.股票出现异动，股价大幅上涨5.02%。Personalis, Inc.股票所在的生命科学行业中，整体涨幅为0.20%。其相关个股中，Exagen Inc.、Personalis, Inc.、Inotiv, Inc.涨幅较大，Ispecimen Inc.、Applied Dna Sciences, Inc.、Exagen Inc.较为活跃，换手率分别为0.94%、0.90%、0.70%，振幅较大的相关个股有Genedx Holdings Corp.、Genedx Holdings Corp C/Wts 22/07/2026 、Prophase Labs, Inc.，振幅分别为8.26%、7.77%、7.68%。Personalis, Inc.公司简介：Personalis Inc 是一家基因组测序和分析解决方案提供商，支持个性化癌症疫苗和其他下一代癌症免疫疗法的开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730213912a46bb75a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730213912a46bb75a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","PSNL"],"gpt_icon":0},{"id":"2555225709","title":"Personalis, Inc.盘中异动 股价大跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555225709","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555225709?lang=zh_cn&edition=full","pubTime":"2025-07-29 03:54","pubTimestamp":1753732491,"startTime":"0","endTime":"0","summary":"北京时间2025年07月29日03时54分，Personalis, Inc.股票出现波动，股价大幅下挫5.01%。Personalis, Inc.股票所在的生命科学行业中，整体跌幅为0.23%。其相关个股中，Advanced Biomed Inc.、Genedx Holdings Corp.、纽勤涨幅较大，Applied Dna Sciences, Inc.、Ispecimen Inc.、Endra Life Sciences Inc.较为活跃，换手率分别为14.39%、6.96%、4.67%，振幅较大的相关个股有Advanced Biomed Inc.、Genedx Holdings Corp C/Wts 22/07/2026 、Prophase Labs, Inc.，振幅分别为21.99%、14.73%、13.71%。Personalis, Inc.公司简介：Personalis Inc 是一家基因组测序和分析解决方案提供商，支持个性化癌症疫苗和其他下一代癌症免疫疗法的开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507290354519723cbb0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507290354519723cbb0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","PSNL"],"gpt_icon":0},{"id":"2518222648","title":"Personalis, Inc.盘中异动 大幅下挫5.80%报3.90美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518222648","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518222648?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:34","pubTimestamp":1741613647,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时34分，Personalis, Inc.股票出现异动，股价急速下跌5.80%。截至发稿，该股报3.90美元/股，成交量2.5378万股，换手率0.03%，振幅2.33%。Personalis, Inc.股票所在的生命科学行业中，整体跌幅为0.38%。Personalis, Inc.公司简介：Personalis Inc 是一家基因组测序和分析解决方案提供商，以支持个性化癌症疫苗和其他下一代癌症免疫疗法的开发。其产品包括ImmunoID NeXT, NeXT Personal, NeXT Dx Test和其他制药研究解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213407a26a25ae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213407a26a25ae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","PSNL"],"gpt_icon":0},{"id":"2517455647","title":"Personalis, Inc.2024财年实现净利润-81.28百万美元，同比增加24.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517455647","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517455647?lang=zh_cn&edition=full","pubTime":"2025-03-08 00:00","pubTimestamp":1741363250,"startTime":"0","endTime":"0","summary":"3月8日，Personalis, Inc.公布财报，公告显示公司2024财年净利润为-81.28百万美元，同比增加24.74%；其中营业收入为84.61百万美元，同比增加15.15%，每股基本收益为-1.37美元。从资产负债表来看，Personalis, Inc.总负债67.31百万美元，其中短期债务9.37百万美元，资产负债比为0.05，流动比率为0.07。机构评级：截至2025年3月8日，当前有4家机构对Personalis, Inc.目标价做出预测，其中目标均价为7.75美元，其中最低目标价为7.00美元，最高目标价为9.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250308000205abed6670&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250308000205abed6670&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PSNL"],"gpt_icon":0},{"id":"2517949953","title":"Personalis, Inc.盘中异动 急速上涨5.11%报4.32美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517949953","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517949953?lang=zh_cn&edition=full","pubTime":"2025-03-05 23:51","pubTimestamp":1741189919,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日23时51分，Personalis, Inc.股票出现异动，股价大幅拉升5.11%。Personalis, Inc.股票所在的生命科学行业中，整体涨幅为0.34%。其相关个股中，Biodesix, Inc.、Neuronetics, Inc.、Oncocyte Corporation涨幅较大，Neuronetics, Inc.、Ispecimen Inc.、Grail, Inc.较为活跃，换手率分别为2.37%、2.00%、1.31%，振幅较大的相关个股有Bioaffinity Technologies, Inc.、Oncocyte Corporation、Neuronetics, Inc.，振幅分别为17.70%、16.61%、16.55%。Personalis, Inc.公司简介：Personalis Inc 是一家基因组测序和分析解决方案提供商，以支持个性化癌症疫苗和其他下一代癌症免疫疗法的开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305235159989d594f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305235159989d594f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","PSNL"],"gpt_icon":0},{"id":"2516967074","title":"Personalis, Inc.盘中异动 早盘股价大跌6.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516967074","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516967074?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:33","pubTimestamp":1741098785,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时33分，Personalis, Inc.股票出现波动，股价快速下挫6.33%。Personalis, Inc.股票所在的生命科学行业中，整体跌幅为0.09%。其相关个股中，Neuronetics, Inc.、Xwell, Inc.、Prenetics Global涨幅较大，Biodesix, Inc.、Ispecimen Inc.、Natera, Inc.较为活跃，换手率分别为2.03%、0.77%、0.71%，振幅较大的相关个股有Xwell, Inc.、安奈特保险、Neuronetics, Inc.，振幅分别为9.25%、6.97%、6.79%。Personalis, Inc.公司简介：Personalis Inc 是一家基因组测序和分析解决方案提供商，以支持个性化癌症疫苗和其他下一代癌症免疫疗法的开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223305963944d9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223305963944d9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","PSNL"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.personalis.com","stockEarnings":[{"period":"1week","weight":-0.0404},{"period":"1month","weight":0.0011},{"period":"3month","weight":0.0293},{"period":"6month","weight":0.3549},{"period":"1year","weight":0.6411},{"period":"ytd","weight":0.103}],"compareEarnings":[{"period":"1week","weight":0.0028},{"period":"1month","weight":0.0176},{"period":"3month","weight":0.043},{"period":"6month","weight":0.1047},{"period":"1year","weight":0.1933},{"period":"ytd","weight":0.0174}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Personalis, Inc.于2011年2月21日在特拉华州注册成立，并于2011年9月开始运营。该公司是一家不断发展的癌症基因组学公司，通过提供有关每位患者癌症和免疫反应的更全面的分子数据，改变下一代疗法的发展。该公司设计其NeXT平台以适应对癌症的复杂和不断发展的理解，为其生物制药客户提供有关所有大约20,000个人类基因以及免疫系统的信息，而许多癌症小组覆盖大约50到500个基因。他们还在开发一种补充液体活检分析，分析所有人类基因与目前可用的更集中的液体活检分析。通过结合技术创新，运营规模和监管差异化，他们的NeXT平台旨在帮助他们的客户获得对治疗反应和抗药性机制以及新的潜在治疗目标的新见解。","yearOnYearQuotes":[{"month":1,"riseRate":0.571429,"avgChangeRate":-0.045441},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.041102},{"month":3,"riseRate":0,"avgChangeRate":-0.128549},{"month":4,"riseRate":0.5,"avgChangeRate":-0.023404},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.05661},{"month":6,"riseRate":0.666667,"avgChangeRate":0.075481},{"month":7,"riseRate":0.571429,"avgChangeRate":0.27723},{"month":8,"riseRate":0.571429,"avgChangeRate":0.076793},{"month":9,"riseRate":0.142857,"avgChangeRate":-0.07131},{"month":10,"riseRate":0.428571,"avgChangeRate":-0.003099},{"month":11,"riseRate":0.428571,"avgChangeRate":0.014792},{"month":12,"riseRate":0.714286,"avgChangeRate":0.136788}],"exchange":"NASDAQ","name":"Personalis","nameEN":"Personalis"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Personalis(PSNL)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Personalis(PSNL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Personalis,PSNL,Personalis股票,Personalis股票老虎,Personalis股票老虎国际,Personalis行情,Personalis股票行情,Personalis股价,Personalis股市,Personalis股票价格,Personalis股票交易,Personalis股票购买,Personalis股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Personalis(PSNL)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Personalis(PSNL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}